Caveolin 3

Last updated

CAV3
Identifiers
Aliases CAV3 , LGMD1C, LQT9, VIP-21, VIP21, caveolin 3, MPDT, RMD2
External IDs OMIM: 601253; MGI: 107570; HomoloGene: 7255; GeneCards: CAV3; OMA:CAV3 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_033337
NM_001234

NM_007617

RefSeq (protein)

NP_001225
NP_203123

NP_031643

Location (UCSC) Chr 3: 8.73 – 8.84 Mb Chr 6: 112.44 – 112.45 Mb
PubMed search [3] [4]
Wikidata
View/Edit Human View/Edit Mouse

Caveolin-3 is a protein that in humans is encoded by the CAV3 gene. [5] [6] [7] Alternative splicing has been identified for this locus, with inclusion or exclusion of a differentially spliced intron. In addition, transcripts utilize multiple polyA sites and contain two potential translation initiation sites.

Contents

Function

This gene encodes a caveolin family member, which functions as a component of the caveolae plasma membranes found in most cell types. Caveolin proteins are proposed to be scaffolding proteins for organizing and concentrating certain caveolin-interacting molecules. [7]

Clinical significance

Mutations identified in this gene lead to interference with protein oligomerization or intra-cellular routing, disrupting caveolae formation and resulting in Limb-Girdle muscular dystrophy type-1C (LGMD-1C), HyperCKemia, distal myopathy or rippling muscle disease (RMD). Other mutations in Caveolin causes Long QT Syndrome or familial hypertrophic cardiomyopathy, although the role of Cav3 in Long QT syndrome has recently been disputed. [7] [8]

Interactions

Caveolin 3 has been shown to interact with a range of different proteins, including, but not limited to:

Structure

Using transmission electron microscopy and single particle analysis methods, it has been shown that nine Caveolin-3 monomers assemble to form a complex that is toroidal in shape, ~16.5 nm in diameter and ~5.5 nm in height. [13]

Cardiac physiology

Caveolin-3 is one of three isoforms of the protein caveolin. [14] Caveolin-3 is concentrated in the caveolae of myocytes, and modulates numerous metabolic processes including: nitric oxide synthesis, cholesterol metabolism, and cardiac myocytes contraction. [14] [15] [16] There are many proteins that associate with caveolin-3, including ion channels and exchangers. [14] [17] [18] [19] [20] [21] [22] [23]

Associations with ion channels

ATP-dependent potassium channels

In cardiac myocytes, caveolin-3 negatively regulates ATP-dependent potassium channels (KATP) localized in caveolae. [18] KATP channel opening decreases significantly when interacting with caveolin-3; other isoforms of caveolin do not show this type of effect on KATP channels. The amount of KATP activation during times of biological stress influences the amount of cellular damage that will occur, thus regulation of caveolin-3 expression during these times influences the amount of cellular damage. [18]

Sodium-calcium exchanger

Caveolin-3 associates with the cardiac sodium-calcium exchanger (NCX) in caveolae of cardiac myocytes. [14] [24] This association occurs predominately in areas proximate to the peripheral membrane of cardiac myocytes. [24] Interactions between caveolin-3 and cardiac NCX influence NCX-regulation of cellular signaling factors and excitation of cardiac myocytes. [14]

L-Type calcium channel

Caveolin-3 influences the opening of L-Type calcium channels (LTCC) which play a role in cardiac myocyte contraction. [17] Disruption of interactions between caveolin-3 and its associated binding proteins has been shown to affect LTCC. [17] Specifically, disruption of caveolin-3 decreases the basal and b2-adrenergic-stimulated opening probabilities of LTCC. [17] This occurs by changing the PKA-mediated phosphorylation of caveolin-3-associated binding proteins, causing negative down-stream effects on LTCC activity. [17]

Implications in disease

Alterations in caveolin-3 expression have been implicated in the altered expression and regulation of numerous signaling molecules involved in cardiomyopathies. [21] Disruption of caveolin-3 disturbs the structure of cardiac caveolae and blocks atrial natriuretic peptide (ANP) expression, a cardiac-related hormone involved in many functions including maintaining cellular homeostasis. [21] [25] Normal caveolin-3 expression under conditions of stress increases cardiac cellular levels of ANP, maintaining cardiac homeostasis. [21] Mutations have been identified in the caveolin-3 gene that result in cardiomyopathies. [20] Several of these mutations influence caveolin-3 function by reducing the expression of its cell-surface domains. [19] Mutations resulting in loss-of-function of caveolin-3 cause cardiac myocyte hypertrophy, dilation of the heart, and depression of fractional shortening. [22] [23] Knockout of caveolin-3 genes are sufficient to induce these manifestations. [25] Similarly, dominant-negative genotypes for caveolin-3 increase cardiac hypertrophy, whereas increased expression of caveolin-3 inhibits the ability of the heart to hypertrophy, implicating caveolin-3 as a negative regulator of cardiac hypertrophy. [22] [23] Overexpression of caveolin-3 leads to the development of cardiomyopathy, resulting in degeneration of cardiac tissue and manifesting pathologies due to the associated degeneration. [19]

Related Research Articles

In biology, caveolae, which are a special type of lipid raft, are small invaginations of the plasma membrane in the cells of many vertebrates. They are the most abundant surface feature of many vertebrate cell types, especially endothelial cells, adipocytes and embryonic notochord cells. They were originally discovered by E. Yamada in 1955.

In molecular biology, caveolins are a family of integral membrane proteins that are the principal components of caveolae membranes and involved in receptor-independent endocytosis. Caveolins may act as scaffolding proteins within caveolar membranes by compartmentalizing and concentrating signaling molecules. They also induce positive (inward) membrane curvature by way of oligomerization, and hairpin insertion. Various classes of signaling molecules, including G-protein subunits, receptor and non-receptor tyrosine kinases, endothelial nitric oxide synthase (eNOS), and small GTPases, bind Cav-1 through its 'caveolin-scaffolding domain'.

<span class="mw-page-title-main">Dysferlin</span> Protein encoded by the DYSF gene in humans

Dysferlin also known as dystrophy-associated fer-1-like protein is a protein that in humans is encoded by the DYSF gene. Dysferlin is linked with plasma membrane repair., stabilization of calcium signaling and the development of the T-tubule system of the muscle A defect in the DYSF gene, located on chromosome 2p12-14, results in several types of muscular dystrophy; including Miyoshi myopathy (MM), Limb-girdle muscular dystrophy type 2B (LGMD2B) and Distal Myopathy (DM). A reduction or absence of dysferlin, termed dysferlinopathy, usually becomes apparent in the third or fourth decade of life and is characterised by weakness and wasting of various voluntary skeletal muscles. Pathogenic mutations leading to dysferlinopathy can occur throughout the DYSF gene.

<span class="mw-page-title-main">Desmoplakin</span> Protein found in humans

Desmoplakin is a protein in humans that is encoded by the DSP gene. Desmoplakin is a critical component of desmosome structures in cardiac muscle and epidermal cells, which function to maintain the structural integrity at adjacent cell contacts. In cardiac muscle, desmoplakin is localized to intercalated discs which mechanically couple cardiac cells to function in a coordinated syncytial structure. Mutations in desmoplakin have been shown to play a role in dilated cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy, where it may present with acute myocardial injury; striate palmoplantar keratoderma, Carvajal syndrome and paraneoplastic pemphigus.

<span class="mw-page-title-main">HADHB</span> Protein-coding gene in the species Homo sapiens

Trifunctional enzyme subunit beta, mitochondrial (TP-beta) also known as 3-ketoacyl-CoA thiolase, acetyl-CoA acyltransferase, or beta-ketothiolase is an enzyme that in humans is encoded by the HADHB gene.

<span class="mw-page-title-main">Caveolin 1</span> Protein found in humans

Caveolin-1 is a protein that in humans is encoded by the CAV1 gene.

<span class="mw-page-title-main">RAS p21 protein activator 1</span> Protein-coding gene in the species Homo sapiens

RAS p21 protein activator 1 or RasGAP, also known as RASA1, is a 120-kDa cytosolic human protein that provides two principal activities:

<span class="mw-page-title-main">TNNT2</span> Protein-coding gene in the species Homo sapiens

Cardiac muscle troponin T (cTnT) is a protein that in humans is encoded by the TNNT2 gene. Cardiac TnT is the tropomyosin-binding subunit of the troponin complex, which is located on the thin filament of striated muscles and regulates muscle contraction in response to alterations in intracellular calcium ion concentration.

<span class="mw-page-title-main">GATA4</span> Protein-coding gene in the species Homo sapiens

Transcription factor GATA-4 is a protein that in humans is encoded by the GATA4 gene.

<span class="mw-page-title-main">Myocyte-specific enhancer factor 2A</span> Protein-coding gene in the species Homo sapiens

Myocyte-specific enhancer factor 2A is a protein that in humans is encoded by the MEF2A gene. MEF2A is a transcription factor in the Mef2 family. In humans it is located on chromosome 15q26. Certain mutations in MEF2A cause an autosomal dominant form of coronary artery disease and myocardial infarction.

<span class="mw-page-title-main">PRKAG2</span> Protein-coding gene in the species Homo sapiens

5'-AMP-activated protein kinase subunit gamma-2 is an enzyme that in humans is encoded by the PRKAG2 gene.

<span class="mw-page-title-main">ATP2A1</span> Protein-coding gene in the species Homo sapiens

Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 (SERCA1) also known as Calcium pump 1, is an enzyme that in humans is encoded by the ATP2A1 gene.

<span class="mw-page-title-main">Integrin alpha 7</span>

Alpha-7 integrin is a protein that in humans is encoded by the ITGA7 gene. Alpha-7 integrin is critical for modulating cell-matrix interactions. Alpha-7 integrin is highly expressed in cardiac muscle, skeletal muscle and smooth muscle cells, and localizes to Z-disc and costamere structures. Mutations in ITGA7 have been associated with congenital myopathies and noncompaction cardiomyopathy, and altered expression levels of alpha-7 integrin have been identified in various forms of muscular dystrophy.

<span class="mw-page-title-main">Delta-sarcoglycan</span> Mammalian protein found in Homo sapiens

Delta-sarcoglycan is a protein that in humans is encoded by the SGCD gene.

<span class="mw-page-title-main">PHOX2A</span> Protein-coding gene in humans

Paired mesoderm homeobox protein 2A is a protein that in humans is encoded by the PHOX2A gene.

<span class="mw-page-title-main">AKAP1</span> Protein-coding gene in the species Homo sapiens

A kinase anchor protein 1, mitochondrial is an enzyme that in humans is encoded by the AKAP1 gene.

<span class="mw-page-title-main">Triadin</span> Protein-coding gene in humans

Triadin, also known as TRDN, is a human gene associated with the release of calcium ions from the sarcoplasmic reticulum triggering muscular contraction through calcium-induced calcium release. Triadin is a multiprotein family, arising from different processing of the TRDN gene on chromosome 6. It is a transmembrane protein on the sarcoplasmic reticulum due to a well defined hydrophobic section and it forms a quaternary complex with the cardiac ryanodine receptor (RYR2), calsequestrin (CASQ2) and junctin proteins. The luminal (inner compartment of the sarcoplasmic reticulum) section of Triadin has areas of highly charged amino acid residues that act as luminal Ca2+ receptors. Triadin is also able to sense luminal Ca2+ concentrations by mediating interactions between RYR2 and CASQ2. Triadin has several different forms; Trisk 95 and Trisk 51, which are expressed in skeletal muscle, and Trisk 32 (CT1), which is mainly expressed in cardiac muscle.

<span class="mw-page-title-main">MYOZ1</span> Protein-coding gene in the species Homo sapiens

Myozenin-1 is a protein that in humans is encoded by the MYOZ1 gene.

<span class="mw-page-title-main">Caveolin 2</span> Protein found in humans

Caveolin-2 is a protein that in humans is encoded by the CAV2 gene.

<span class="mw-page-title-main">Ankyrin-3</span> Protein-coding gene in the species Homo sapiens

Ankyrin-3 (ANK-3), also known as ankyrin-G, is a protein from ankyrin family that in humans is encoded by the ANK3 gene.

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000182533 Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000062694 Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. McNally EM, de Sá Moreira E, Duggan DJ, Bönnemann CG, Lisanti MP, Lidov HG, Vainzof M, Passos-Bueno MR, Hoffman EP, Zatz M, Kunkel LM (August 1998). "Caveolin-3 in muscular dystrophy". Hum Mol Genet. 7 (5): 871–7. doi: 10.1093/hmg/7.5.871 . PMID   9536092.
  6. Minetti C, Sotgia F, Bruno C, Scartezzini P, Broda P, Bado M, Masetti E, Mazzocco M, Egeo A, Donati MA, Volonte D, Galbiati F, Cordone G, Bricarelli FD, Lisanti MP, Zara F (April 1998). "Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy". Nat Genet. 18 (4): 365–8. doi:10.1038/ng0498-365. PMID   9537420. S2CID   35061895.
  7. 1 2 3 "Entrez Gene: CAV3 caveolin 3".
  8. Hedley PL, Kanters JK, Dembic M, Jespersen T, Skibsbye L, Aidt FH, Eschen O, Graff C, Behr ER, Schlamowitz S, Corfield V, McKenna WJ, Christiansen M (2013). "The Role of CAV3 in Long-QT Syndrome: Clinical and Functional Assessment of a Caveolin-3/Kv11.1 Double Heterozygote Versus Caveolin-3 Single Heterozygote". Circ Cardiovasc Genet. 6 (5): 452–61. doi: 10.1161/CIRCGENETICS.113.000137 . PMID   24021552.
  9. Sotgia F, Lee JK, Das K, Bedford M, Petrucci TC, Macioce P, Sargiacomo M, Bricarelli FD, Minetti C, Sudol M, Lisanti MP (December 2000). "Caveolin-3 directly interacts with the C-terminal tail of beta -dystroglycan. Identification of a central WW-like domain within caveolin family members". J. Biol. Chem. 275 (48): 38048–58. doi: 10.1074/jbc.M005321200 . PMID   10988290.
  10. Matsuda C, Hayashi YK, Ogawa M, Aoki M, Murayama K, Nishino I, Nonaka I, Arahata K, Brown RH (August 2001). "The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle". Hum. Mol. Genet. 10 (17): 1761–6. doi: 10.1093/hmg/10.17.1761 . PMID   11532985.
  11. Couet J, Sargiacomo M, Lisanti MP (November 1997). "Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities". J. Biol. Chem. 272 (48): 30429–38. doi: 10.1074/jbc.272.48.30429 . PMID   9374534.
  12. Whiteley G, Collins RF, Kitmitto A (November 2012). "Characterization of the molecular architecture of human caveolin-3 and interaction with the skeletal muscle ryanodine receptor". J. Biol. Chem. 287 (48): 40302–16. doi: 10.1074/jbc.M112.377085 . PMC   3504746 . PMID   23071107.
  13. Whiteley G, Collins RF, Kitmitto A (Nov 23, 2012). "Characterization of the molecular architecture of human caveolin-3 and interaction with the skeletal muscle ryanodine receptor". The Journal of Biological Chemistry. 287 (48): 40302–16. doi: 10.1074/jbc.M112.377085 . PMC   3504746 . PMID   23071107.
  14. 1 2 3 4 5 Bossuyt J, Taylor BE, James-Kracke M, Hale CC (2002). "Evidence for cardiac sodium-calcium exchanger association with caveolin-3". FEBS Lett. 511 (1–3): 113–7. doi: 10.1016/S0014-5793(01)03323-3 . PMID   11821059. S2CID   19419069.
  15. Gazzerro E, Sotgia F, Bruno C, Lisanti MP, Minetti C (2010). "Caveolinopathies: from the biology of caveolin-3 to human diseases". Eur. J. Hum. Genet. 18 (2): 137–45. doi:10.1038/ejhg.2009.103. PMC   2987183 . PMID   19584897.
  16. Gratton JP, Bernatchez P, Sessa WC (2004). "Caveolae and caveolins in the cardiovascular system". Circ. Res. 94 (11): 1408–17. doi: 10.1161/01.RES.0000129178.56294.17 . PMID   15192036.
  17. 1 2 3 4 5 Bryant S, Kimura TE, Kong CH, Watson JJ, Chase A, Suleiman MS, James AF, Orchard CH (2014). "Stimulation of ICa by basal PKA activity is facilitated by caveolin-3 in cardiac ventricular myocytes". J. Mol. Cell. Cardiol. 68 (100): 47–55. doi:10.1016/j.yjmcc.2013.12.026. PMC   3980375 . PMID   24412535.
  18. 1 2 3 Garg V, Sun W, Hu K (2009). "Caveolin-3 negatively regulates recombinant cardiac K(ATP) channels". Biochem. Biophys. Res. Commun. 385 (3): 472–7. doi:10.1016/j.bbrc.2009.05.100. PMID   19481058.
  19. 1 2 3 Aravamudan B, Volonte D, Ramani R, Gursoy E, Lisanti MP, London B, Galbiati F (2003). "Transgenic overexpression of caveolin-3 in the heart induces a cardiomyopathic phenotype". Hum. Mol. Genet. 12 (21): 2777–88. doi: 10.1093/hmg/ddg313 . PMID   12966035.
  20. 1 2 Hayashi T, Arimura T, Ueda K, Shibata H, Hohda S, Takahashi M, Hori H, Koga Y, Oka N, Imaizumi T, Yasunami M, Kimura A (January 2004). "Identification and functional analysis of a caveolin-3 mutation associated with familial hypertrophic cardiomyopathy". Biochem. Biophys. Res. Commun. 313 (1): 178–84. doi:10.1016/j.bbrc.2003.11.101. PMID   14672715.
  21. 1 2 3 4 Horikawa YT, Panneerselvam M, Kawaraguchi Y, Tsutsumi YM, Ali SS, Balijepalli RC, Murray F, Head BP, Niesman IR, Rieg T, Vallon V, Insel PA, Patel HH, Roth DM (2011). "Cardiac-specific overexpression of caveolin-3 attenuates cardiac hypertrophy and increases natriuretic peptide expression and signaling". J. Am. Coll. Cardiol. 57 (22): 2273–83. doi:10.1016/j.jacc.2010.12.032. PMC   3236642 . PMID   21616289.
  22. 1 2 3 Koga A, Oka N, Kikuchi T, Miyazaki H, Kato S, Imaizumi T (2003). "Adenovirus-mediated overexpression of caveolin-3 inhibits rat cardiomyocyte hypertrophy". Hypertension. 42 (2): 213–9. doi: 10.1161/01.HYP.0000082926.08268.5D . PMID   12847114.
  23. 1 2 3 Woodman SE, Park DS, Cohen AW, Cheung MW, Chandra M, Shirani J, Tang B, Jelicks LA, Kitsis RN, Christ GJ, Factor SM, Tanowitz HB, Lisanti MP (2002). "Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade". J. Biol. Chem. 277 (41): 38988–97. doi: 10.1074/jbc.M205511200 . PMID   12138167.
  24. 1 2 Lin E, Hung VH, Kashihara H, Dan P, Tibbits GF (2009). "Distribution patterns of the Na+-Ca2+ exchanger and caveolin-3 in developing rabbit cardiomyocytes". Cell Calcium. 45 (4): 369–83. doi:10.1016/j.ceca.2009.01.001. PMID   19250668.
  25. 1 2 Nakajima K, Onishi K, Dohi K, Tanabe M, Kurita T, Yamanaka T, Ito M, Isaka N, Nobori T, Nakano T (2005). "Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels". Int. J. Cardiol. 104 (3): 332–7. doi:10.1016/j.ijcard.2004.12.020. PMID   16186065.

Further reading